Correlation Between Pmv Pharmaceuticals and Passage Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Passage Bio, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Passage Bio.

Diversification Opportunities for Pmv Pharmaceuticals and Passage Bio

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pmv and Passage is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Passage Bio go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Passage Bio

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Passage Bio. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 1.57 times less risky than Passage Bio. The stock trades about -0.02 of its potential returns per unit of risk. The Passage Bio is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  66.00  in Passage Bio on August 25, 2024 and sell it today you would lose (15.00) from holding Passage Bio or give up 22.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pmv Pharmaceuticals  vs.  Passage Bio

 Performance 
       Timeline  
Pmv Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Pmv Pharmaceuticals is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.
Passage Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Passage Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pmv Pharmaceuticals and Passage Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pmv Pharmaceuticals and Passage Bio

The main advantage of trading using opposite Pmv Pharmaceuticals and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.
The idea behind Pmv Pharmaceuticals and Passage Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Money Managers
Screen money managers from public funds and ETFs managed around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes